1Center of Genomics and Bioinformatics, Institute of Agriculture and Natural Sciences, Deen Dayal Upadhyay Gorakhpur University, Gorakhpur-273009, Uttar Pradesh, India
2Department of Genetics and Plant Breeding, DDU Gorakhpur University, Gorakhpur-273009, Uttar Pradesh, India
3Department of Genetics and Plant Breeding, BRD PG College, Deoria-274001, Uttar Pradesh, India
4College of Agriculture, CSKHPKV, Palampur-176062, Himachal Pradesh, India
5Department of Biotechnology, School of Applied and Life Sciences, Uttaranchal University, Dehradun-248007, India
6College of Horticulture and Forestry, Thunag-175048, Himachal Pradesh, India
7College of Community Sciences, CSKHPKV, Palampur-176062, Himachal Pradesh, India
*Corresponding author e-mail: sonikakalia.266@gmail.com
Online published on 25 July, 2025.
MicroRNAs are small, non-coding RNA molecules that have regulatory control over the miscellaneous biological activities in plants and animals. Medicinal plants are a rich repository of secondary metabolites that exhibit a wide variety of therapeutic properties. The functional regulation of miRNAs to regulate secondary metabolism is still inadequately understood. Similarly, the role of multiple target regulation systems for single miRNAs is poorly known. The functional significance of the variables, applications, and approaches of different miRNAs that influence secondary metabolite control are investigated in this review. This review article focuses on secondary metabolite control by diverse miRNA families, growing miRNA techniques, and cross-kingdom regulation of plant miRNAs on human health in depth. Here, challenging and limiting aspects of miRNA research have been covered. The role of Phyto miRNAs as a dietary supplement in the prevention of diseases such as COVID-19 has been debated. We offer an update and address the implications of plant miRNA mediated secondary metabolite control, as well as the potential for this interesting regulatory mechanism to be used as an enhanced therapy for a variety of diseases.
MiRNA, Secondary metabolites, Medicinal plants, MAPs, COVID-19, Biosynthesis, Medicinal plants